Baxter Bros Inc’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$961K Hold
1,710
0.12% 91
2025
Q4
$1.16M Hold
1,710
0.13% 86
2025
Q3
$1.09M Hold
1,710
0.13% 85
2025
Q2
$917K Hold
1,710
0.11% 89
2025
Q1
$718K Hold
1,710
0.09% 95
2024
Q4
$707K Hold
1,710
0.09% 94
2024
Q3
$864K Hold
1,710
0.11% 85
2024
Q2
$833K Sell
1,710
-570
-25% -$286K 0.11% 82
2024
Q1
$1.23M Hold
2,280
0.16% 75
2023
Q4
$1.27M Hold
2,280
0.18% 72
2023
Q3
$997K Hold
2,280
0.15% 79
2023
Q2
$1.15M Hold
2,280
0.17% 74
2023
Q1
$1.14M Hold
2,280
0.18% 73
2022
Q4
$930K Hold
2,280
0.15% 75
2022
Q3
$743K Buy
2,280
+400
+21% +$147K 0.13% 78
2022
Q2
$659K Hold
1,880
0.12% 81
2022
Q1
$1.03M Hold
1,880
0.15% 73
2021
Q4
$1.24M Hold
1,880
0.18% 71
2021
Q3
$1.17M Hold
1,880
0.19% 69
2021
Q2
$1.19M Hold
1,880
0.19% 67
2021
Q1
$920K Hold
1,880
0.16% 70
2020
Q4
$940K Hold
1,880
0.18% 70
2020
Q3
$739K Sell
1,880
-50
-3% -$18.5K 0.16% 70
2020
Q2
$637K Sell
1,930
-170
-8% -$49.2K 0.15% 72
2020
Q1
$509K Hold
2,100
0.13% 78
2019
Q4
$548K Buy
+2,100
New +$553K 0.11% 85

Other funds holding IDXX

Baxter Bros Inc's IDXX Position: Q1 2026 in Review

Baxter Bros Inc held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 1,710 shares worth $961K. The position accounts for 0.12% of the portfolio, ranked #91.

Baxter Bros Inc first reported a position in IDXX in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.27M in Q4 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Baxter Bros Inc held 1,710 shares of Idexx Laboratories worth $961K as of Q1 2026.
  • Baxter Bros Inc left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.12% of Baxter Bros Inc's portfolio in Q1 2026, its #91 holding.
  • Baxter Bros Inc first reported a position in Idexx Laboratories in Q4 2019 and has held it in 26 quarters since.
  • Baxter Bros Inc's Idexx Laboratories position peaked at $1.27M in Q4 2023.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Baxter Bros Inc's 13F filing for Q1 2026, filed 28 Apr 2026.